South Australian toddler dies, meningococcal suspected
A South Australian toddler has died from a suspected case of meningococcal disease. SA Health says the 18-month-old died at the Women’s and Children’s Hospital in Adelaide on Sunday afternoon. The authority will run tests on Monday to confirm if meningococcal – a form of meningitis with flu-like symptoms – was responsible for the death. […]
Eighth WA case of meningococcal disease reported for 2017
The Department of Health today reported that a young child has been discharged from hospital after being diagnosed with serogroup B meningococcal disease. Meningococcal disease is an uncommon, life-threatening illness caused by a bacterial infection of the blood and/or the membranes that line the spinal cord and brain, and occasionally of other sites, such as […]
Five month wait for Meningococcal B-strain vaccination
SOUTH Australian families desperate to safeguard their children’s health are being forced to wait up to five months for their children to be vaccinated against the deadly meningoco ccal B disease. The Advertiser can reveal one Adelaide pharmacy has a waiting list of 125 people wanting the Bexsero vaccine, as global demand for the drug […]
Meningococcal B vaccine could soon be available in Australia
A FREE vaccine for a deadly strain of meningococcal could soon be available in Australia following a decision by the federal government to fast-track its consideration. Health Minister Greg Hunt has ordered the nation’s chief medical officer consider whether vaccinations for meningococcal B strains should be placed on the taxpayer-funded schedule after it was added […]
Meningococcal case confirmed in North Tasmania
A meningococcal case has been confirmed in a child who attends the Abacus Child Care centre at Trevallyn. Public Health acting director Dr Mark Veitch said the child was receiving care in hospital. There had been three cases of invasive meningococcal disease in Tasmania in 2017, Dr Veitch said, with one in the North and two in […]
Two-Year-Old South Australian Boy Diagnosed With Meningococcal Disease This is the third case in the state so far in 2017.
A toddler from regional South Australia has been hospitalised with an invasive case of Meningococcal Disease, the fourth case in the state in the past three months. The two-year-old boy has been admitted to hospital and remains in a stable condition, according to a statement released on Tuesday by South Australia Health. Multiple people have […]
Free Vaccines for SA Students: Can This Meningococcal B Study Stop Teens From Spreading the Disease?
Free Vaccines for SA Students: Can This Meningococcal B Study Stop Teens From Spreading the Disease? · Student Edge News Articles This month, researchers at the University of Adelaide will provide free meningococcal B vaccines for up to 60,000 students in years 10, 11 and 12. It’s part of what is believed to be the […]
Free meningococcal vaccine for NSW teenagers to protect against W strain of disease
Free meningococcal vaccine for NSW teenagers to protect against W strain of disease – ABC News (Australian Broadcasting Corporation) A free vaccination program to protect teenagers from the W strain of the deadly meningococcal disease has been announced by the New South Wales Government. The announcement has come after pressure from lobby group Meningococcal […]
WA Govt offers free meningococcal vaccines for teenagers
A vaccination to protect against meningococcal strains A, C, W and Y will be offered to 15-19 year olds in an Australian-first, statewide program to start in school Term 2. The campaign is in response to a concerning increase in the number of meningococcal W cases in WA and other States and Territories. The incidence […]
Pfizer Gets EU Nod For Nimenrix To Treat Invasive Meningococcal Disease for Babies
Pfizer Inc. (PFE) announced Monday that the European Commission has approved an expanded indication for Nimenrix for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y in infants as early as six weeks of age. The EU approval is based upon results from a Phase 3, open-label, randomized, […]